Valnoctamide
Valnoctamide (INN, USAN) has been used in France as a sedative-hypnotic since 1964. It is a structural isomer of valpromide, a valproic acid prodrug; unlike valpromide, however, valnoctamide is not transformed into its homologous acid, valnoctic acid, in vivo.
Names | |
---|---|
Preferred IUPAC name
2-Ethyl-3-methylpentanamide | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.021.849 |
EC Number |
|
KEGG | |
MeSH | valnoctamide |
PubChem CID |
|
RTECS number |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C8H17NO | |
Molar mass | 143.230 g·mol−1 |
Appearance | White crystals |
log P | 1.885 |
Pharmacology | |
N05CM13 (WHO) | |
| |
Pharmacokinetics: | |
94% | |
Hepatic | |
10 hours | |
Hazards | |
GHS labelling: | |
Warning | |
H302 | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose) |
760 mg kg−1 (oral, rat) |
Related compounds | |
Related alkanamides |
Valpromide |
Related compounds |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.